The Verdict
One year after losing a historical $2.25 billion trial in Pennsylvania, a jury ordered Roundup makers Bayer and Monsanto to pay another $2 billion in damages in late March—this time to a Georgia man diagnosed with Non-Hodgkin’s Lymphoma.
Nearly the entire $2 billion verdict was awarded as punitive damages meant to punish Bayer and Monsanto for acting in poor conduct, like last year’s trial. The remaining $65 million was awarded as compensatory damages meant to cover the plaintiff’s medical bills, missed wages, and other losses.
The plaintiff, according to his attorney, used Roundup around his home for 20 years before he was diagnosed with cancer in 2020. After the trial, Attorney Kyle Findley spoke to The Associated Press about the verdict, calling it an “important milestone” after “another example of Monsanto’s refusal to accept responsibility for poisoning people with this toxic product.”
Like with every other Roundup trial that didn’t quite go their way, Bayer and Monsanto are planning to appeal the verdict. Though it’s likely the decision won’t be fully overturned, there’s a fair chance it could be reduced due to the value of the awarded punitive damages being so large.
What does this mean for the Roundup lawsuit?
Based on some of Bayer and Monsanto’s latest actions, this verdict makes it clear they can’t afford to keep losing more of these billion-dollar trials. But instead of working with lawsuit participants to come up with a solution, they still insist on protecting themselves by manipulating lawmakers, seeking immunity from courts, and trying to push state laws that would prevent cancer victims from being compensated.
For years now, Bayer has openly admitted to lobbying federal and state lawmakers to achieve the legislation it wants. And, just weeks before the $2 billion verdict in Georgia, an insider revealed that Bayer told legislators that it would stop selling Roundup in the U.S. if they did not introduce more laws that would protect them from cancer lawsuits.
Not only that, but after losing another trial in October 2024, Bayer and Monsanto requested that the U.S. Supreme Court hear their appeal of a decision made in a previous Roundup trial. Whether or not the Court will take their case on is still unclear, but a Supreme Court hearing could drastically shake up the current state of the Roundup lawsuit.
File a Roundup cancer compensation claim
Affected by the original version of Roundup weed killer? Now’s the time to join the lawsuit before Bayer and Monsanto take further action to block cancer claims. If you or a family member were diagnosed with Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, B-Cell Lymphoma, T-Cell Lymphoma, or another type of blood cancer after using Roundup, check your eligibility for a settlement today.
